Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 5/20 | 0.79 |
| ▸ | MGLL | Q99685 | 1/20 | 0.60 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.49 |
| ▸ | XDH | P47989 | 1/20 | 0.47 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.47 |
| ▸ | P4HB | P07237 | 1/20 | 0.44 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.44 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.44 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.44 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.44 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 2/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29953646 | 1.00 | ENPP2 (0.79) | ENPP2MGLLCLK4XDHSLC22A12 | |
| SCHEMBL4883 | 0.88 | ENPP2 (1.00) | ENPP2MGLLCLK4P4HB | |
| SCHEMBL30002811 | 0.88 | ENPP2 (1.00) | ENPP2MGLLCLK4P4HB | |
| SCHEMBL16016598 | 0.87 | ENPP2 (0.65) | ENPP2MGLLCLK4XDHSLC22A12 | |
| SCHEMBL16016633 | 0.87 | ENPP2 (0.65) | ENPP2MGLLXDHSLC22A12PTPN5 | |
| SCHEMBL16016558 | 0.86 | MGLL (0.68) | ENPP2MGLLCLK4XDHSLC22A12 | |
| SCHEMBL31139484 | 0.82 | MGLL (0.86) | ENPP2MGLL | |
| SCHEMBL2154026 | 0.82 | CLK4 (0.65) | ENPP2CLK4XDHSLC22A12PTPN5 | |
| SCHEMBL12619984 | 0.82 | MGLL (0.86) | ENPP2MGLL | |
| SCHEMBL30712840 | 0.82 | MGLL (0.86) | ENPP2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230128259-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2023-04-27 | — | — | US | disclosed |
| CN-113045553-A | Aza-aromatic compound used as electron transport material and application thereof | 烟台显华化工科技有限公司 | 2021-06-29 | — | — | CN | disclosed |
| CN-112125892-A | Compound, electron transport material and organic electroluminescent device | 烟台显华化工科技有限公司 | 2020-12-25 | — | — | CN | disclosed |
| WO-2020197170-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | 주식회사 엘지화학 | 2020-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230128259-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | L1CAM, CRY1, CRY2 | ENPP2 3992/4885MGLL 1438/4885CLK4 2266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.